高科石化(002778.SZ):持股6.8363%股東擬減持不超6%股份
格隆匯4月20日丨高科石化(002778.SZ)公佈,持股6.8363%的股東上海金融發展投資基金(有限合夥),計劃自公告之日起3個工作日後的6個月內,通過大宗交易、集中競價方式或其他合法方式減持公司股份合計不超過534.657萬股,即不超過公司總股本的6%。
其中,通過集中競價方式減持的,將於減持計劃公告之日起15個交易日後進行,即從2020年5月15日起至2020年11月14日止,且任意連續90個自然日內通過證券交易所集中競價交易減持股份的總數不超過公司總股本的1%。通過大宗交易方式的,在任意連續90個自然日內,減持股份的總數不得超過公司股份總數的2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.